Table 3.
Overall proportion of patients who met the quality-of-care indicators
| Indicator | No. (%) of patients* n = 343 |
|---|---|
| Cases detected by screening | 13 (3.8) |
| Adequate colon evaluation | 324 (94.5) |
| Preoperative liver imaging | 313 (91.2) |
| Preoperative pelvis imaging in patients with rectal cancer (n = 95) | 91 (95.8) |
| Patients with rectal cancer who received NEORT (n = 75) | 47 (62.7) |
| Patients with rectal cancer who received NEOCT (n = 75) | 45 (60.0) |
| Completeness of operative report, mean score ± SD† | 4.04 ± 2.9 |
| Completeness of pathology report | |
| Reported no. of lymph nodes examined | 322 (93.9) |
| Reported ≥ 12 lymph nodes examined (n = 322) | 265 (82.3) |
| Reported positive lymph nodes (n = 322) | 115 (35.7) |
| No. of lymph nodes collected, mean ± SD | 18.3 ± 10.0 |
| Reported quantitative distal margin status | 271 (79.0) |
| Reported quantitative circumferential margin status | 36 (10.5) |
| Reported distal margin ≥ 1 cm in patients with rectal cancer (n = 68) | 66 (97.0) |
| Anastomotic leak in patients with rectal cancer (n = 95) | 5 (5.3) |
| In-hospital/30-d mortality | 11 (3.2) |
| Local recurrence | |
| Within 2 yr after surgery for rectal cancer and colon cancer | 23 (6.7) |
| Following rectal cancer | 7 (7.4) |
| Surveillance colonoscopy within 1 yr after surgery (n = 260) | 154 (59.2) |
NEOCT = neoadjuvant chemotherapy; NEORT = neoadjuvant radiotherapy; SD = standard deviation.
*
Except where noted otherwise.
†
Maximum possible score: 10.